 Despite this, many patents (1035 patents, up to October 2018, according to the Scifinder data base) on molecular imprinting were held by different groups.Commercial interest is also confirmed by the fact that MIP Technologies, offers a range of commercially available MIP products and Sigma-Aldrich produces SupelMIP for beta-agonists, beta-blockers, pesticides and some drugs of abuse such as amphetamine.Additionally, POLYINTELL designs, manufactures and markets AFFINIMIPSPE products for instance for mycotoxins such as patulin, zearalenone, fumonisins, ochratoxin A, for endocrine disruptors (bisphenol A, estrogen derivatives etc...) or for the purification of radiotracers before their use in positron emission tomography (PET).